MedPath
HSA Approval

BORTESUN POWDER FOR SOLUTION FOR INJECTION 3.5 MG/ VIAL

SIN15594P

BORTESUN POWDER FOR SOLUTION FOR INJECTION 3.5 MG/ VIAL

BORTESUN POWDER FOR SOLUTION FOR INJECTION 3.5 MG/ VIAL

December 10, 2018

RANBAXY (MALAYSIA) SDN. BHD.

RANBAXY (MALAYSIA) SDN. BHD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRANBAXY (MALAYSIA) SDN. BHD.
Licence HolderRANBAXY (MALAYSIA) SDN. BHD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS, SUBCUTANEOUS

Medical Information

L01XX32

xl 01 xx 32

Manufacturer Information

RANBAXY (MALAYSIA) SDN. BHD.

SUN PHARMACEUTICAL INDUSTRIES LIMITED

Active Ingredients

BORTEZOMIB

3.5mg/vial

Bortezomib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BORTESUN POWDER FOR SOLUTION FOR INJECTION 3.5 MG/ VIAL - HSA Approval | MedPath